58200-88-7 + 56-91-7 + 75-75-2 = 81525-10-2 反应条件:1.1 Reagents: Dicyclohexylcarbodiimide Solvents: Pyridine 标题:Synthesis And Structure-Activity Study Of Protease Inhibitors. Iv. Amidinonaphthols And Related Acyl Derivatives 作者:Aoyama,Takuo; Et Al 参考文献:Chemical & Pharmaceutical Bulletin 日期:1985 卷标:33(4) 页码:1458-71]
16060-65-4 = 81525-10-2 [标题:Reaction Conditions 标题:Amidine Compounds And Anticomplement Agent Comprising Them 参考文献:European Patent Organization]
58200-88-7 + 42823-46-1 + 75-75-2 = 81525-10-2 + 75-75-2 反应条件:1.1 Reagents: Cyanuric Chloride,4-Methylmorpholine; 4 H,60 °C1.2 Overnight,Rt1.3 Reagents: Sodium Bicarbonate Solvents: Water; 10 Min,Rt1.4 Solvents: Methanol 标题:Tct-Mediated Process For The Preparation Of Nafamostat Mesylate And Camostat Mesylate 作者:Ahmed,Riyaz; Et Al 参考文献:Chemistryselect 日期:2023 卷标:8(18)]
= 81525-10-2 + 75-75-2 反应条件:1.1 Reagents: Hydrogen Peroxide Solvents: Water; < 10 °C; 30 Min,0 °C2.1 Solvents: Peracetic Acid; 0.5 H,0 °C; 0 °C -> Rt; Overnight,Rt3.1 Reagents: Potassium Carbonate Solvents: Water; 0.5 H,Rt3.2 Reagents: Hydrochloric Acid Solvents: Methanol; 0.5 H,Rt4.1 Reagents: Cyanuric Chloride,4-Methylmorpholine; 4 H,60 °C4.2 Overnight,Rt4.3 Reagents: Sodium Bicarbonate Solvents: Water; 10 Min,Rt4.4 Solvents: Methanol 标题:Tct-Mediated Process For The Preparation Of Nafamostat Mesylate And Camostat Mesylate 作者:Ahmed,Riyaz; Et Al 参考文献:Chemistryselect 日期:2023 卷标:8(18)]
344349-96-8 + 60131-35-3 = 81525-10-2 [标题:Reaction Conditions 标题:Amidine Compounds And Anticomplement Agent Comprising Them 参考文献:European Patent Organization]
58200-88-7 + 42823-46-1 + 75-75-2 = 81525-10-2 反应条件:1.1 Reagents: Dicyclohexylcarbodiimide Solvents: Pyridine 标题:Synthesis And Structure-Activity Study Of Protease Inhibitors. Iv. Amidinonaphthols And Related Acyl Derivatives 作者:Aoyama,Takuo; Et Al 参考文献:Chemical & Pharmaceutical Bulletin 日期:1985 卷标:33(4) 页码:1458-71
专利号:US-2025188022-A1 优先权日:2022-02-07 标 题 :Process for the preparation of nafamostat, camostat and their derivatives 发明人:AHMED RIYAZ; KUMAR GULSHAN; MAHAJAN SHEENA; Verma Praveen Kumar; CHAM PANKAJ SINGH; KUMAR AMIT; AHMED QAZI NAVEED; REDDY DUMBALA SRINIVASA; SHANKAR RAVI; SINGH PARVINDER PAL 权利人:COUNCIL SCIENT IND RES 摘要:The invention provides a novel, economical and practical route for the synthesis of an ester from acid and alcoholic functionalities using Trihalotriazine as coupling agent. Specifically, the invention provides a novel, economical and practical route for the preparation of Nafamostat and Camostat. Synthesis of p-guanidinobenzoic acid (Al) was also achieved from thiourea and p-aminobenzoic acid by using trihalotriazine as coupling reagent.
专利号:WO-2008103866-A1 优先权日:2007-02-22 标题 :Synthesis of indoles 发明人:TALLEY JOHN JEFFREY; RENZE JUERGEN T 权利人:MICROBIA INC; TALLEY JOHN JEFFREY; RENZE JUERGEN T 摘要:Method for preparing indoles, including methods that permit high yield production of particular compounds, are described.
专利号:US-9023813-B2 优先权日:2011-04-13 标题:Synthesis and use of glycoside derivatives of propofol 发明人:SHULL BRIAN; BALDWIN JOHN; GOPALASWAMY RAMESH; HAROON ZISHAN 权利人:SHULL BRIAN; BALDWIN JOHN; GOPALASWAMY RAMESH; HAROON ZISHAN; NUTEK PHARMA LTD 摘要:The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug propofol analogs. This invention relates to a method for the production of a broad group of glycosylated propofol carbohydrate derivatives.
专利号:US-2012295866-A1 优先权日:2011-04-13 标题:Synthesis And Use Of Glycoside Pro-Drug Analogs 发明人:SHULL BRIAN; BALDWIN JOHN; GOPALASWAMY RAMESH; HAROON ZISHAN 权利人:SHULL BRIAN; BALDWIN JOHN; GOPALASWAMY RAMESH; HAROON ZISHAN; NUTEK PHARMA LTD 摘要:The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs. This invention relates to a method for the production of a broad group of glycosylated drugs, including but not limited to propofol, acetaminophen, and camptothecin carbohydrate derivatives.
专利号:CN-220143394-U 优先权日:2023-06-21 标题 :A kind of synthesis device for the production of nafamostat mesylate
专利号:US-2012264702-A1 优先权日:2011-04-13 标题 :Synthesis And Use Of Glycoside Derivatives of Propofol
1: Wang W, Zhao J, Zhang X, Wang L, Zhang X, Zhang Z, Qian S. Comparison of Anticoagulant Effects of Nafamostat Mesilate and Heparin in Continuous Renal Replacement Therapy for Patients with High Bleeding Risk: A Meta-Analysis Systemic Review. Kidney Dis (Basel). 2026 Feb 3;12(1):302-317. doi: 10.1159/000550804. 2: Wang Y, He Q, Wen D, Xu R, Yu X, Zhao L. Efficacy and safety of nafamostat mesylate versus heparin anticoagulation in adult kidney disease patients using continuous renal replacement therapy: a systematic review and meta-analysis. Front Med (Lausanne). 2026 Feb 17;13:1713412. doi: 10.3389/fmed.2026.1713412. 3: Liu C, Yang Y, Ren J, Huang Y, Wei W, Li X, Wang F, Tang X, Fu P, Zhang L, Zhao Y. Nafamostat mesilate as anticoagulant for blood purification: a systematic review and meta-analysis. Crit Care. 2025 Dec 24;30(1):43. doi: 10.1186/s13054-025-05813-w.
合成参考文献
摘要:Takahashi H. [Synthetic protease inhibitors for the treatment of DIC]. Rinsho Byori. 2011 Feb;Suppl 147():152–8. 参考文献:10.1097/mpa.0b013e31822116d5 摘要:Park KT, Kang DH, Choi CW, Cho M, Park SB, Kim HW, Kim DU, Chung CW, Yoon KT. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients Pancreas. 2011 Nov;40(8):1215–9. doi: 10.1097/mpa.0b013e31822116d5.